Biostar Pharmaceuticals, Inc.: 10-Q filed 2012-11-19
What Biostar Pharmaceuticals, Inc. reported in its quarterly report filed 2012-11-19 (fiscal Q3 2012): 36 published measures, 100 facts as tagged in accession 0001185185-12-002603.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-11-19
- Fiscal period
- fiscal Q3 2012
- Accession
- 0001185185-12-002603 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Biostar Pharmaceuticals, Inc. filings.
Reported measures
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 64,121,553 | USD | |
| At 2011-12-31 | 76,401,700 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 12,119,565 | USD | |
| At 2011-12-31 | 16,971,789 | USD | |
| At 2011-09-30 | 24,006,839 | USD | |
| At 2010-12-31 | 13,211,443 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -5,939,635 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -13,254,772 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 4,463,737 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 11,339,884 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | -5,015,466 | USD | 274 |
| 2011-01-01 to 2011-09-30 | 11,847,880 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | 32,784 | USD | 274 |
| 2011-01-01 to 2011-09-30 | 105,488 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | -791,176 | USD | 274 |
| 2011-01-01 to 2011-09-30 | 782,656 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | 905,384 | USD | 274 |
| 2011-01-01 to 2011-09-30 | -2,296,925 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 30,219,062 | USD | |
| At 2011-12-31 | 43,473,834 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 9,490,506 | shares | 92 |
| 2012-01-01 to 2012-09-30 | 9,430,532 | shares | 274 |
| 2011-07-01 to 2011-09-30 | 9,398,876 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 9,264,104 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 9,490,506 | shares | 92 |
| 2012-01-01 to 2012-09-30 | 9,430,532 | shares | 274 |
| 2011-07-01 to 2011-09-30 | 9,398,876 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 9,264,104 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -0.63 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | -1.41 | USD/shares | 274 |
| 2011-07-01 to 2011-09-30 | 0.47 | USD/shares | 92 |
| 2011-01-01 to 2011-09-30 | 1.22 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -0.63 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | -1.41 | USD/shares | 274 |
| 2011-07-01 to 2011-09-30 | 0.47 | USD/shares | 92 |
| 2011-01-01 to 2011-09-30 | 1.22 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 198,508 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -1,376,356 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 1,599,316 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 4,539,127 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 7,038,982 | USD | |
| At 2011-12-31 | 7,379,982 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -5,795,862 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -14,845,875 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 5,938,341 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 15,616,824 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 48,551,386 | USD | |
| At 2011-12-31 | 60,508,809 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 1,059 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 33,193 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 2,984 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 10,371 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 4,187,849 | USD | |
| At 2011-12-31 | 6,660,176 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 9,390,806 | USD | |
| At 2011-12-31 | 10,406,931 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 28,815,263 | USD | |
| At 2011-12-31 | 35,033,650 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 11,035,343 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 35,494,752 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 11,375,113 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 31,011,393 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 985,274 | USD | |
| At 2011-12-31 | 1,373,459 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 5,239,481 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 20,648,877 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 17,313,454 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 46,628,217 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 789,702 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 2,370,605 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 9,993,549 | shares | |
| At 2011-12-31 | 9,400,216 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 23,238,700 | USD | |
| At 2011-12-31 | 22,445,660 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 4,163,198 | USD | |
| At 2011-12-31 | 3,982,206 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 8,896,232 | USD | |
| At 2011-12-31 | 8,891,462 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 1,857,250 | USD | |
| At 2011-12-31 | 1,511,480 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 9,390,806 | USD | |
| At 2011-12-31 | 10,406,931 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 5,390,773 | USD | |
| At 2011-12-31 | 7,129,911 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -6,056,924 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -13,073,780 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 5,103,856 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 13,073,470 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 2,640,240 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 5,124,789 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 983,778 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 4,103,154 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 54,735 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 214,747 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 124,712 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 262,187 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | 2,547,289 | USD | 274 |
| 2011-01-01 to 2011-09-30 | 2,931,921 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | -392,153 | USD | 274 |
| 2011-01-01 to 2011-09-30 | 1,448,494 | USD | 273 |
Inspect the source
- Entity
- Biostar Pharmaceuticals, Inc. / CIK 0001418133
- Captured
- SEC response SHA-256
65bfcb22925fcd8d50013fde5b00c59d0adcec0a6e09b2504502010fb5944726
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001418133.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))